Enrolling
CTN 339: The NOVA-HIV Study
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV
Learn MoreEnrolling
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV
Learn MoreReporting
Ongoing
A study of an HPV VLP vaccine in a cohort of HIV positive girls and women
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.